Mirjam de With
0000-0002-9953-7945
6 papers found
Refreshing results…
Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy
Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma
Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients
Missing publications? Search for publications with a matching author name.